REQUEST A DEMO
Total
USD $0.00
Search more companies

Global Therapeutics S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Global Therapeutics S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Global Therapeutics S.A.S. is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 13, 2015. It currently has a total number of 5 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 132.99% in 2023. Over the same period, its total assets grew by 56.84%. In, 2023, the company’s net profit margin decreased by 0.19%.

Headquarters
Avenida Carrera 15 # 106-32 Oficina 607
Bogota D.C.; Bogota D.C; Postal Code: 0811

Contact Details: Purchase the Global Therapeutics S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Global Therapeutics S.A.S. report to view the information.
Outstanding Shares:
Purchase the Global Therapeutics S.A.S. report to view the information.
Incorporation Date:
July 13, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Global Therapeutics S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
132.99%
Total operating revenue
132.99%
Operating profit (EBIT)
351.8%
Net Profit (Loss) for the Period
125.14%
Total assets
56.84%
Total equity
8.63%
Operating Profit Margin (ROS)
5.26%
Net Profit Margin
-0.19%
Return on Equity (ROE)
43.26%
Quick Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?